Learning Objectives:-

- Understand the role of cardiac testing for clearance to return to sports after MIS-C
- Learn the potential cardiac complications of MIS-C
- Describe the current epidemiologic trends and pathophysiology of COVID-19 associated MIS-C in the United States.
- Plan the differential diagnosis and initial work-up in a patient with suspected MIS-C.
- Know the current guidelines for use of immunomodulatory therapy for MIS-C


Session date: 
09/28/2021 - 4:30pm to 5:30pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Julia Rosebush, DO, FAAP; Melissa Tesher, MD; Paula E. Williams, MD, MS